Drug Patents owned by Journey

1. List of Amzeeq drug patents

Patent Number Company Patent Title Patent Expiry Activity Alert
These patents focus on the other aspects of the active substance like dosage, mode of administration (oral, tablet, capsules, liquids etc).
US8945516 JOURNEY Surfactant-free water-free foamable compositions, breakable foams and gels and their uses
Oct, 2030

(7 years from now)

US10137200 JOURNEY Surfactant-free water-free foamable compositions, breakable foams and gels and their uses
Oct, 2030

(7 years from now)

US8865139 JOURNEY Topical tetracycline compositions
Oct, 2030

(7 years from now)

US9675700 JOURNEY Topical tetracycline compositions
Oct, 2030

(7 years from now)

US8992896 JOURNEY Topical tetracycline compositions
Oct, 2030

(7 years from now)

US10086080 JOURNEY Topical tetracycline compositions
Oct, 2030

(7 years from now)

US10213512 JOURNEY Topical tetracycline compositions
Oct, 2030

(7 years from now)

US10517882 JOURNEY Method for healing of an infected acne lesion without scarring
Oct, 2030

(7 years from now)

US10821187 JOURNEY Compositions, gels and foams with rheology modulators and uses thereof
Oct, 2030

(7 years from now)

US10265404 JOURNEY Compositions, gels and foams with rheology modulators and uses thereof
Oct, 2030

(7 years from now)

US10849847 JOURNEY Compositions and methods for treating rosacea and acne
Sep, 2037

(14 years from now)

US10398641 JOURNEY Compositions and methods for treating rosacea and acne
Sep, 2037

(14 years from now)

Drugs and Companies using MINOCYCLINE HYDROCHLORIDE ingredient

Market Authorisation Date: 18 October, 2019

Treatment: Treatment of non-nodular acne vulgaris

Dosage: AEROSOL, FOAM;TOPICAL

How can I launch a generic of AMZEEQ before it's patent expiration?
More Information on Dosage

2. List of Qbrexza drug patents

Patent Number Company Patent Title Patent Expiry Activity Alert
These patents protects the active chemical substance. Only patent owner can launch products that use this active substance.
US10548875 JOURNEY Glycopyrrolate salts
Feb, 2033

(10 years from now)

These patents focus on the other aspects of the active substance like dosage, mode of administration (oral, tablet, capsules, liquids etc).
US10052267 JOURNEY Topical glycopyrrolate formulations
Oct, 2028

(5 years from now)

US8618160 JOURNEY Topical glycopyrrolate formulations
Dec, 2029

(6 years from now)

US9744105 JOURNEY Topical glycopyrrolate formulations
Jul, 2030

(7 years from now)

US10004717 JOURNEY Glycopyrrolate salts
Feb, 2033

(10 years from now)

US9259414 JOURNEY Glycopyrrolate salts
Feb, 2033

(10 years from now)

US10543192 JOURNEY Glycopyrrolate salts
Feb, 2033

(10 years from now)

US8859610 JOURNEY Crystalline glycopyrrolate tosylate
Feb, 2033

(10 years from now)

Drugs and Companies using GLYCOPYRRONIUM TOSYLATE ingredient

Market Authorisation Date: 28 June, 2018

Treatment: Topical treatment of primary axillary hyperhidrosis in adults and pediatric patients 9 years of age and older

Dosage: CLOTH;TOPICAL

How can I launch a generic of QBREXZA before it's patent expiration?
More Information on Dosage

3. List of Ximino drug patents

Patent Number Company Patent Title Patent Expiry Activity Alert
These patents focus on the other aspects of the active substance like dosage, mode of administration (oral, tablet, capsules, liquids etc).
US8252776 JOURNEY Minocycline oral dosage forms for the treatment of acne
Jun, 2025

(2 years from now)

US8268804 JOURNEY Minocycline oral dosage forms for the treatment of acne
Jun, 2025

(2 years from now)

US7790705 JOURNEY Minocycline oral dosage forms for the treatment of acne
Jun, 2025

(2 years from now)

US7919483 JOURNEY Method for the treatment of acne
Mar, 2027

(4 years from now)

US7544373 JOURNEY Minocycline oral dosage forms for the treatment of acne
Apr, 2027

(4 years from now)

US7541347 JOURNEY Minocycline oral dosage forms for the treatment of acne
Apr, 2027

(4 years from now)

Drugs and Companies using MINOCYCLINE HYDROCHLORIDE ingredient

Market Authorisation Date: 11 July, 2012

Treatment: Treatment of acne; Treatment of inflammatory lesions of non-nodular moderate to severe acne vulgaris

Dosage: CAPSULE, EXTENDED RELEASE;ORAL

More Information on Dosage

4. List of Zilxi drug patents

Patent Number Company Patent Title Patent Expiry Activity Alert
These patents focus on the other aspects of the active substance like dosage, mode of administration (oral, tablet, capsules, liquids etc).
US10213512 JOURNEY Topical tetracycline compositions
Oct, 2030

(7 years from now)

US8992896 JOURNEY Topical tetracycline compositions
Oct, 2030

(7 years from now)

US9675700 JOURNEY Topical tetracycline compositions
Oct, 2030

(7 years from now)

US8865139 JOURNEY Topical tetracycline compositions
Oct, 2030

(7 years from now)

US10322186 JOURNEY Topical tetracycline compositions
Oct, 2030

(7 years from now)

US10946101 JOURNEY Surfactant-free water-free foamable compositions, breakable foams and gels and their uses
Oct, 2030

(7 years from now)

US8945516 JOURNEY Surfactant-free water-free foamable compositions, breakable foams and gels and their uses
Oct, 2030

(7 years from now)

US10265404 JOURNEY Compositions, gels and foams with rheology modulators and uses thereof
Oct, 2030

(7 years from now)

Drugs and Companies using MINOCYCLINE HYDROCHLORIDE ingredient

Market Authorisation Date: 28 May, 2020

Treatment: Treatment of inflammatory lesions of rosacea.

Dosage: AEROSOL, FOAM;TOPICAL

How can I launch a generic of ZILXI before it's patent expiration?
More Information on Dosage

availability in other generic markets.

Click on the highlighted region to filter.

900+ leading pharmaceutical companies are staying up-to-date with drug patents through Pharsight

Join them to stay ahead in capturing the next drug going generic

Other things you might be interested in